(Q33971276)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899429%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

review article

1 reference

title

Oligomerizaiton and fibril asssembly of the amyloid-beta protein (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899429%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899429%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

A E Roher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899429%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J Baudry

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899429%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M O Chaney

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899429%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

W B Stine

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899429%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M R Emmerling

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899429%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

English

0 references

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899429%20AND%20SRC:MED&resulttype=core&format=json

Biochimica et Biophysica Acta

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899429%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

1502

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899429%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899429%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

31-43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899429%20AND%20SRC:MED&resulttype=core&format=json

Normal and abnormal biology of the beta-amyloid precursor protein

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

The "nonamyloidogenic" p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Neuritic plaque amyloid in Alzheimer's disease is highly racemized

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

The effects of aspartic acid-bond isomerization on in vitro properties of the amyloid beta-peptide as modeled with N-terminal decapeptide fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Polyclonals to beta-amyloid(1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

In vitro production of beta-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

ALZHEIMER'S DISEASE--AN ELECTRON MICROSCOPICAL STUDY

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

The complex of microglial cells and amyloid star in three-dimensional reconstruction.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Amyloid beta-peptide is produced by cultured cells during normal metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Characterization of beta-amyloid peptide from human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Alzheimer's soluble amyloid beta is a normal component of human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Combined influence of cholesterol and synthetic amphiphillic peptides upon bilayer thickness in model membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Relationships between lipid membrane area, hydrophobic thickness, and acyl-chain orientational order. The effects of cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Cholesterol and the Golgi apparatus

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Hydrophobic mismatch and the incorporation of peptides into lipid bilayers: a possible mechanism for retention in the Golgi

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

A comparison of the transmembrane domains of Golgi and plasma membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Functions of lipid rafts in biological membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Functional rafts in cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Control of the transmembrane orientation and interhelical interactions within membranes by hydrophobic helix length.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Transmembrane orientation of hydrophobic alpha-helices is regulated both by the relationship of helix length to bilayer thickness and by the cholesterol concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Cholesterol-dependent generation of a unique amyloid beta-protein from apically missorted amyloid precursor protein in MDCK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II).

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Decreased myelin lipids in Alzheimer's disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Light-induced coupling of aqueous-soluble proteins to liposomes formed from carbene-generating phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

VMD: visual molecular dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

"Secretase," Alzheimer amyloid protein precursor secreting enzyme is not sequence-specific

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Beta-amyloid precursor protein cleavage by a membrane-bound protease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Interactions of alpha-helices with lipid bilayers: a review of simulation studies

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Beta-amyloid precursor protein. Location of transmembrane domain and specificity of gamma-secretase cleavage

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Solution Structures of β Peptide and Its Constituent Fragments: Relation to Amyloid Deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Kinetics of aggregation of synthetic beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Rapid induction of Alzheimer A beta amyloid formation by zinc.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Zinc and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Alzheimer's: could there be a zinc link?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Fibrillogenesis of synthetic amyloid-beta peptides is dependent on their initial secondary structure

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Arrest of beta-amyloid fibril formation by a pentapeptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

A strategy for designing inhibitors of beta-amyloid toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Molecular modeling of the Abeta1-42 peptide from Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Endogenous proteins controlling amyloid beta-peptide polymerization. Possible implications for beta-amyloid formation in the central nervous system and in peripheral tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Complement activation by beta-amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Appearance of sodium dodecyl sulfate-stable amyloid beta-protein (Abeta) dimer in the cortex during aging

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Amyloid beta-protein (A beta) accumulation in the putamen and mammillary body during aging and in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Amyloid P component and other acute-phase proteins associated with cerebellar A beta-deposits in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Inhibition of Alzheimer β-Peptide Fibril Formation by Serum Amyloid P Component

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein/NAC precursor that bind Abeta and NAC

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Sulfated glycosaminoglycans in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Binding of amyloid beta-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Ultrastructural studies of amyloid fibrils and senile plaques in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

High-resolution electron microscopic analysis of the amyloid fibril in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffraction.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

β-Sheet topology and the relatedness of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Structural properties of protein β-sheets

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Multivalent binding of complement protein C1Q to the amyloid beta-peptide (A beta) promotes the nucleation phase of A beta aggregation.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-sheet helix

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Observation of metastable Abeta amyloid protofibrils by atomic force microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

A molecular model of Alzheimer amyloid beta-peptide fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Lipid binding to amyloid beta-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Alzheimer's amyloid beta interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Amyloid beta-protein (A beta) associated with lipid molecules: immunoreactivity distinct from that of soluble A beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Distribution and fluidizing action of soluble and aggregated amyloid beta-peptide in rat synaptic plasma membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Alzheimer's disease: coated vesicles, coated pits and the amyloid-related cell.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Collagen fibril assembly and deposition in the developing dermis: segmental deposition in extracellular compartments

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Basement membranes, microfibrils and beta amyloid fibrillogenesis in Alzheimer's disease: high resolution ultrastructural findings

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Inflammation and Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900030-2

7 January 2021

10.1016/S0925-4439(00)00030-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899429%20AND%20SRC:MED&resulttype=core&format=json

release_z6uunrqmcrd23gdvpukmknqptq

8 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z6uunrqmcrd23gdvpukmknqptq

24 November 2022

mapped directly with Wikidata item

1 reference